{"id":"https://openalex.org/W2328299075","doi":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","title":"PD03-08: BRCA1-Like Triple Negative Tumors: Clinicopathological Variables and Chemosensitivity to Alkylating Agents.","display_name":"PD03-08: BRCA1-Like Triple Negative Tumors: Clinicopathological Variables and Chemosensitivity to Alkylating Agents.","publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2328299075","doi":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","mag":"2328299075"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs11-pd03-08","doi":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020517461","display_name":"Jelle Wesseling","orcid":"https://orcid.org/0000-0002-8940-2676","observed_orcids":["https://orcid.org/0000-0002-8940-2676"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J Wesseling","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061164455","display_name":"EH Lips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"EH Lips","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009673808","display_name":"AMM Oonk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"AMM Oonk","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066528308","display_name":"RM Smits","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"RM Smits","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112086490","display_name":"CCM van Rijn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"CCM van Rijn","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070619938","display_name":"Lennart Mulder","orcid":"https://orcid.org/0000-0001-8844-1481","observed_orcids":["https://orcid.org/0000-0001-8844-1481"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L Mulder","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011913289","display_name":"Nadja Laddach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"N Laddach","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082625578","display_name":"SS Savola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"SS Savola","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020129085","display_name":"Lodewyk F.A. Wessels","orcid":"https://orcid.org/0000-0002-1656-6995","observed_orcids":["https://orcid.org/0000-0002-1656-6995"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"LFA Wessels","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084801062","display_name":"P.M. Nederlof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"PM Nederlof","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111726498","display_name":"Sjoerd Rodenhuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S Rodenhuis","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067719431","display_name":"Alexander L.T. Imholz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210129008","display_name":"MRC Holland (Netherlands)","ror":"https://ror.org/02wcat891","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210129008"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"ALT Imholz","raw_affiliation_strings":["1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Deventer Hospital, Deventer, Netherlands; MRC-Holland, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210129008"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24548502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"24_Supplement","first_page":"PD03","last_page":"08"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.08579999953508377,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/brcaness","display_name":"BRCAness","score":0.9359999895095825},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.8009999990463257},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.8399999737739563},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8949999809265137},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.7670000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7379999756813049},{"id":"https://openalex.org/keywords/clinicopathological-variables","display_name":"clinicopathological variables","score":0.6990000009536743},{"id":"https://openalex.org/keywords/node-negative-disease","display_name":"node-negative disease","score":0.6029999852180481},{"id":"https://openalex.org/keywords/t-stage","display_name":"T stage","score":0.5839999914169312},{"id":"https://openalex.org/keywords/array-based-comparative-genomic-hybridization","display_name":"array comparative genomic hybridization","score":0.7559999823570251},{"id":"https://openalex.org/keywords/dna-cross-linking-agents","display_name":"DNA cross-linking agents","score":0.7649999856948853},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6414819955825806},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6356433033943176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6119978427886963},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5922728180885315},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5887619256973267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5583345293998718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5390588045120239},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5064858198165894},{"id":"https://openalex.org/C124942203","wikidata":"https://www.wikidata.org/wiki/Q656638","display_name":"Comparative genomic hybridization","level":4,"score":0.4702305495738983},{"id":"https://openalex.org/C2992734768","wikidata":"https://www.wikidata.org/wiki/Q48964","display_name":"Triple negative","level":4,"score":0.4695228934288025},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3579091429710388},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2833317220211029},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1969616413116455},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11729732155799866},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.07600042223930359},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05814260244369507}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs11-pd03-08","doi":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-pd03-08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126188713","https://openalex.org/W2328900967","https://openalex.org/W2113734556","https://openalex.org/W2559852197","https://openalex.org/W2749757810","https://openalex.org/W2592430155","https://openalex.org/W2120905843","https://openalex.org/W2600305339","https://openalex.org/W2326716637","https://openalex.org/W2170719826"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Our":[2],"group":[3],"has":[4,59],"previously":[5],"employed":[6],"array":[7],"Comparative":[8],"Genomic":[9],"Hybridization":[10],"(aCGH)":[11],"to":[12,24,62,197,207,330,342,355],"assess":[13],"the":[14,208,235,264,349],"genomic":[15],"patterns":[16],"of":[17,51,97,352],"BRCA1-mutated":[18],"breast":[19,56,100,307],"cancers.":[20],"It":[21,338],"is":[22,45],"reasonable":[23],"assume":[25],"that":[26,324],"this":[27],"pattern":[28],"indicates":[29],"\u2018BRCAness\u2019":[30],"and":[31,58,78,90,107,128,143,148,161,171,200,214,226,250,278,303],"thus":[32],"serves":[33],"as":[34,136,334],"a":[35,94,179,190,297],"marker":[36],"for":[37,65,257],"homologous":[38],"recombination":[39],"deficiency.":[40],"This":[41],"BRCA1-like":[42,76,129,170,180,194,225,228,258,272,302,325,345],"aCGH":[43],"profile":[44],"also":[46,347],"present":[47],"in":[48,83,93,222,275,290,299],"about":[49],"half":[50],"all":[52],"triple":[53,98,112,305],"negative":[54,99,113,306],"sporadic":[55],"cancers":[57,308],"been":[60],"shown":[61],"be":[63,198,340],"predictive":[64],"benefit":[66],"from":[67,125],"intensive":[68],"chemotherapy":[69,81,119,314,333],"with":[70,103,111,120,193,210,232,269,288,311,315],"DNA":[71,122],"crosslinking":[72],"agents.":[73,105,317],"To":[74],"study":[75],"tumors":[77,101,114,176,184,195,212,273,289,326,346,354],"conventional":[79,116,312],"dose":[80,117,313],"sensitivity":[82,329,351],"more":[84,202,280],"detail,":[85],"we":[86],"compared":[87,149,168,206],"clinical":[88,142],"factors":[89,145],"survival":[91,155,159,163,223,300],"rates":[92],"uniform":[95],"cohort":[96],"treated":[102],"alkylating":[104,233,316],"Patients":[106,192],"methods":[108],"103":[109],"patients":[110,209,229,277],"received":[115],"adjuvant":[118,332],"doxorubicin/cyclophosphamide.":[121],"was":[123,218,238,245,252,263],"extracted":[124],"tumor":[126],"samples":[127],"profiles":[130],"were":[131,134,146,167,279],"assessed.":[132],"Tumors":[133],"classified":[135],"BRCA1":[137],"-like":[138],"or":[139],"non-BRCA1-like.":[140],"Standard":[141],"histopathological":[144],"determined":[147],"between":[150,169,224,301],"both":[151],"groups.":[152],"Relapse":[153],"free":[154],"(RFS),":[156],"disease":[157,205],"specific":[158],"(DSS)":[160],"overall":[162],"(OS)":[164],"after":[165,230,309],"diagnosis":[166],"non-BRCA1-like":[172,211,260,304],"tumors.":[173,261,337],"Results":[174],"66":[175],"(65%)":[177],"had":[178,201],"profile,":[181],"while":[182],"35":[183],"(35%)":[185],"did":[186,294],"not":[187,295],"show":[188],"such":[189],"profile.":[191],"tended":[196],"younger":[199,276],"often":[203,281],"node-negative":[204],"(p=0.058":[213],"p=0.034,":[215],"respectively).":[216],"There":[217],"no":[219],"significant":[220],"difference":[221,298],"non":[227],"treatment":[231,310],"agents:":[234],"median":[236,243],"RFS":[237],"121":[239],"vs.":[240,247,254],"109":[241],"months,":[242,256],"DSS":[244],"129":[246],"114":[248],"months":[249],"OS":[251],"127":[253],"110":[255],"versus":[259],"T-stage":[262],"only":[265],"variable":[266],"significantly":[267],"associated":[268],"survival.":[270],"Conclusion":[271],"occurred":[274],"node":[282],"negative,":[283],"which":[284],"are":[285],"features":[286],"shared":[287],"BRCA1-mutation":[291],"carriers.":[292],"We":[293],"observe":[296],"These":[318],"results":[319],"confirm":[320],"our":[321],"previous":[322],"findings":[323],"have":[327],"similar":[328],"anthracycline-based":[331],"other":[335],"triple-negative":[336],"will":[339],"important":[341],"establish":[343],"whether":[344],"share":[348],"exquisite":[350],"BRCA-mutated":[353],"PARP-inhibitors.":[356],"Citation":[357],"Information:":[358],"Cancer":[359],"Res":[360],"2011;71(24":[361],"Suppl):Abstract":[362],"nr":[363],"PD03-08.":[364]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}